Wu Po-Ming, Yu Wen-Hao, Chiang Chi-Wu, Wu Chen-Yu, Chen Jia-Shing, Tu Yi-Fang
Department of Pediatrics (P.-M.W., W.-H.Y., C.-Y.W., Y.-F.T.), National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan; School of Medicine for International Students (J.-S.C.), I-Shou University, Kaohsiung; Institute of Clinical Medicine (W.-H.Y., Y.-F.T.), College of Medicine, National Cheng Kung University, Tainan; Institute of Molecular Medicine (C.-W.C.), College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Neurol Genet. 2021 Dec 3;8(1):e646. doi: 10.1212/NXG.0000000000000646. eCollection 2022 Feb.
To investigate the pathogenicity of 2 novel variations, report the clinical and neuroimaging findings, and review the available literature.
Physical examinations, structural neuroimaging studies, and exome sequence analysis were performed. KDM5C constructs were used to study the effect of the variations in transfected cells.
We identified 2 novel variations c.2233C>G and c.3392_3393delAG in the gene harboring from 2 Chinese families with X-linked intellectual disability (ID). The affected male patients exhibited severe ID, short stature, and facial dysmorphism. The 1 with c.3392_3393delAG additionally had epilepsy and autistic spectrum disorder (ASD). Transiently transfected mutant KDM5C constructs both reduced protein expression and stability and decreased histone demethylase activities in cells. Reviewing the available literature, we found that the associated ASD tended to occur in patients with variations near the C-terminus of KDM5C.
We report the clinical, molecular genetic, and pathologic features in patients with novel variations of . The variability of the clinical phenotype in addition to an ID may associate with altered particular parts of KDM5C.
研究2种新变异的致病性,报告临床和神经影像学发现,并回顾现有文献。
进行体格检查、结构神经影像学研究和外显子序列分析。使用KDM5C构建体研究转染细胞中变异的影响。
我们在来自2个患有X连锁智力残疾(ID)的中国家庭的基因中鉴定出2种新变异c.2233C>G和c.3392_3393delAG。受影响的男性患者表现出严重的ID、身材矮小和面部畸形。携带c.3392_3393delAG变异的患者还患有癫痫和自闭症谱系障碍(ASD)。瞬时转染的突变KDM5C构建体均降低了细胞中的蛋白质表达和稳定性,并降低了组蛋白去甲基化酶活性。回顾现有文献,我们发现相关的ASD倾向于发生在KDM5C C末端附近有变异的患者中。
我们报告了具有新变异患者的临床、分子遗传学和病理学特征。除ID外,临床表型的变异性可能与KDM5C特定部位的改变有关。